However, inconsistent with previous findings, the angiogenic capacity of HUVECs was significantly reduced after treatment with culture medium supernatant from renal cancer cells (A498, 786-O) following RNASET2 siRNA intervention relative to the si-NC group (Fig. 3, L and M). Here, RNASET2 is linked to renal carcinoma.